Glargine Promotes Human Colorectal Cancer Cell Proliferation via Upregulation of miR-95

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Hormone and Metabolic Research

• Publication date

  2015-02-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0034-1398564PMID 25671802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.

  2014cited by this paper
• Electronic Medical Record Cancer Incidence over Six Years Comparing New Users of Glargine with New Users of NPH Insulin

  2014cited by this paper
• Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies

  2013cited by this paper
• Insulin Therapy and Risk of Prostate Cancer: a Systematic Review and Meta-Analysis of Observational Studies

  2013cited by this paper
• MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer

  2013cited by this paper
• miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1.

  2013cited by this paper
• Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins?

  2013cited by this paper
• MicroRNA and cancer

  2012cited by this paper
• MEK1 and MEK2 differentially regulate human insulin- and insulin glargine-induced human bladder cancer T24 cell proliferation.

  2012cited by this paper
• Insulin Analogs and Cancer

  2012cited by this paper
• Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis

  2012cited by this paper
• High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.

  2012cited by this paper
• Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

  2012cited by this paper
• Quantitative stem-loop RT-PCR for detection of microRNAs.

  2011cited by this paper
• MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.

  2011cited by this paper
• Glargine Promotes Proliferation of Breast Adenocarcinoma Cell Line MCF-7 via AKT Activation

  2011cited by this paper
• Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

  2010cited by this paper
• Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice

  2010cited by this paper
• Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

  2009cited by this paper
• Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

  2009cited by this paper
• Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cells

  2009cited by this paper
• Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

  2009cited by this paper
• Sorting Nexin 1 Down-Regulation Promotes Colon Tumorigenesis

  2006cited by this paper

• MiR-95-3p/EPM2A/MMP2 contributes to the pathogenesis of severe preeclampsia through the regulation of trophoblast biological behaviour.

  2023cites this paper
• Ascites in ovarian cancer: MicroRNA deregulations and their potential roles in ovarian carcinogenesis

  2021cites this paper
• microRNA‐95 knockdown inhibits epithelial–mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5

  2020cites this paper
• Sorting nexins: A novel promising therapy target for cancerous/neoplastic diseases

  2020cites this paper
• ANNALS OF THE NEW YORK ACADEMY OF SCIENCES MARROW

  2020cites this paper
• miR-95 promotes osteosarcoma growth by targeting SCNN1A

  2020cites this paper
• Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.

  2019cites this paper
• MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.

  2019cites this paper
• Insulin glargine affects the expression of Igf-1r, Insr, and Igf-1 genes in colon and liver of diabetic rats

  2018cites this paper
• Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets

  2017cites this paper
• Diabetes and Cancer: a Review of Current Knowledge.

  2016cites this paper
• Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.

  2016cites this paper
• The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus

  2016cites this paper
• Diabetes and Cancer

  2013cites this paper